GKOS(Glaukos Corporation) · 财务报表

GKOS(Glaukos Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$294.01M$282.86M$314.71M$383.48M$507.44M
毛利润$227.38M$213.88M$239.14M$289.45M$282.76M
营业利润−$32.87M−$82.31M−$128.70M−$122.37M−$199.60M
净利润−$49.59M−$99.19M−$134.66M−$146.37M−$187.69M
经营现金流$24.71M−$33.08M−$57.76M−$61.32M−$14.79M
自由现金流−$23.08M−$63.35M−$78.01M−$67.62M−$22.45M
摊薄每股收益$-1.07$-2.09$-2.78$-2.77$-3.28

Glaukos Corporation GKOS